Skip Ribbon Commands
Skip to main content

Table of Contents2013


  • The Status of Cancer 2013

    Definitive progress has been made against cancer; however, cancer remains a significant problem. The treatment of cancer is one of the most expensive diseases to our nation. Biomedical research will lead to more progress and is a wise investment.

  • What is Cancer?

    There are perhaps as many as 200 different types cancer, which is complex at every level, from populations, to individuals, to specific cancers, to the molecular and genetic defects that drive these cancers.

  • Prevention and Early Detection

    Many of the greatest reductions in the morbidity and mortality of cancer have come from advances in cancer prevention and early detection. Identifying individuals at highest risk of developing cancer can make screening more effective.

  • Making Research Count for Patients: A Continual Pursuit

    Anticancer agents that activate a patient's own immune system are yielding remarkable and durable responses. The FDA approved 11 new drugs, three new uses, and three new technologies. Cancer genomics is beginning to guide cancer diagnosis and treatment.

  • On the Horizons

    Near-term breakthroughs are likely to come from combinations of molecularly targeted therapies based on biology. More research is required prior to the use of small, synthetic non-coding nucleotides as anticancer agents.

  • What is Required for Continued Progress Against Cancer?

    How we conduct the research matters. Innovative efforts in strategic areas are needed if we are to become more efficient and productive.

  • Funding Cancer Research and Biomedical Science Drives Progress

    As a direct result of past federal investments in the NIH, incredible progress has been, and continues to be, made against cancer. However, continued progress is under threat.

  • The AACR Call to Action

    The AACR respectfully urges Congress to designate the NIH and NCI as national priorities and protect the NIH and NCI from further cuts from the sequester.

 

 Please Cite As:

 
American Association for Cancer Research. AACR Cancer Progress Report 2013. Clin Cancer Res 2013;19(Supplement 1):S1-S88​

Please see the editorial​ in Clinical Cancer Research
-->